Veru VERU
NASDAQ VERU
$2.64 +0.06 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Veru (VERU) Change in Account Payables (2015 - 2026)

Veru (VERU) posted quarterly Change in Account Payables of $298223.0 for Q1 2026, up 176.34% year-over-year from $107918.9 in Q1 2025, and up 116.01% quarter-over-quarter from -$1.9 million in Q4 2025.

Veru (VERU) Change in Account Payables (2015 - 2026) Analysis & Trends

Veru (VERU) has reported Change in Account Payables for 12 consecutive years, with $298223.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Account Payables rose 176.34% year-over-year to $298223.0; the TTM figure through Mar 2026 stood at -$2.7 million (down 63.2% YoY), while the FY2025 annual figure was -$2.8 million, up 49.19% from the prior year.
  • Change in Account Payables advanced to $298223.0 in Q1 2026 per VERU's latest filing, from -$1.9 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $15.1 million in Q3 2022 and bottomed at -$11.4 million in Q4 2022.
  • Historically, Change in Account Payables has averaged -$53745.3 across 5 years, with a median of -$581759.0 in 2022.
  • On a YoY basis, Change in Account Payables climbed as much as 1092.62% in 2022 and fell as far as 1786.95% in 2022.
  • Veru's Change in Account Payables stood at -$11.4 million in 2022, then soared by 78.18% to -$2.5 million in 2023, then surged by 48.6% to -$1.3 million in 2024, then plunged by 45.24% to -$1.9 million in 2025, then soared by 116.01% to $298223.0 in 2026.
  • Business Quant data shows VERU's Change in Account Payables at $298223.0 in Q1 2026, -$1.9 million in Q4 2025, and -$860779.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -8.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 37.53 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Veru 60.85 Mn 35.06 Mn - -711,684.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -711,684.00
Jun 30, 2026 -711,684.00
Mar 31, 2026 298,223.00
Mar 31, 2026 298,223.00
Dec 31, 2025 -1.86 Mn
Dec 31, 2025 -1.86 Mn
Sep 30, 2025 -860,779.00
Sep 30, 2025 -860,779.00
Jun 30, 2025 -226,403.00
Jun 30, 2025 -226,403.00
Mar 31, 2025 -390,651.00
Mar 31, 2025 -390,651.00
Dec 31, 2024 -1.28 Mn
Dec 31, 2024 -1.28 Mn
Sep 30, 2024 -258,948.00
Sep 30, 2024 -258,948.00
Jun 30, 2024 307,324.00
Jun 30, 2024 307,324.00
Mar 31, 2024 -2.99 Mn
Mar 31, 2024 -2.99 Mn